Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #173383 on Innovation Pharmaceuticals Inc (IPIX)
BonelessCat
02/26/17 9:57 AM
#173393 RE: xoc #173383
Waverunner1
02/26/17 6:17 PM
#173418 RE: xoc #173383
Even after the past two years of deals, AbbVie's ($ABBV) decision to pay $21 billion for Pharmacyclics, bagging half interest in the blockbuster cancer drug Imbruvica, managed to get jaws to drop among even the most jaded biotech analysts.
PCYC sale was for 21 billion, not 11 billion. Does that change your numbers for CTIX?